Related Experiment Video
Updated: Jul 8, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
The cost of renal dialysis in a UK setting--a multicentre study
Keshwar Baboolal1, Philip McEwan, Seema Sondhi
1Department of Nephrology and Transplantation, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK. BaboolalK@cf.ac.uk
Insights
Automated and continuous ambulatory peritoneal dialysis are the most cost-effective renal replacement therapies. Accurate dialysis cost data is crucial for fair NHS funding and maximizing patient treatment within budget.
Area of Science:
- Nephrology
- Health Economics
Background:
- The UK National Health Service (NHS) is implementing Payment by Results (PbR) for renal services from 2009.
- Accurate cost-reflective tariffs are essential for the success of PbR in renal services.
Purpose of the Study:
- To estimate the cost of different dialysis modalities in UK hospitals.
- To inform the development of accurate renal tariffs for PbR.
Main Methods:
- Utilized semi-structured interviews with healthcare professionals and business managers.
- Employed mixed costing methods, including microcosting and a top-down approach.
- Used published figures and supplier price lists for cost assignment, with Cardiff data applied where necessary.
Main Results:
- Automated peritoneal dialysis (APD) cost £21,655 annually; Continuous Ambulatory Peritoneal Dialysis (CAPD) cost £15,570.
- Hospital-based haemodialysis (HD) cost £35,023/year, satellite-unit HD cost £32,669/year, and home-based HD cost £20,764/year.
- Key cost drivers for PD included solutions and anemia management; for HD, they were disposables, nursing, unit overheads, and anemia management.
Conclusions:
- Renal tariffs must accurately reflect dialysis costs to prevent biased modality choices.
- Understanding true modality costs maximizes patient treatment within limited NHS funds.
Background:
The UK National Health Service (NHS) will fund renal services using Payment by Results (PbR), from 2009. Central to the success of PbR will be the creation of tariffs that reflect the true cost of medical services. We have therefore estimated the cost of different dialysis modalities in the Cardiff and Vale NHS Trust and six other hospitals in the UK.
Methods:
We used semi-structured interviews with nephrologists, head nurses and business managers to identify the steps involved in delivering the different dialysis modalities. We assigned costs to these using published figures or suppliers' published price lists. The study used mixed costing methods. Dialysis costs were estimated by a combination of microcosting and a top-down approach. Where we did not have access to detailed accounts, we applied values for Cardiff.
Results:
The most efficient modalities were automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD), the mean annual costs of which were pound21 655 and pound15 570, respectively. Hospital-based haemodialysis (HD) cost pound35 023 per annum and satellite-unit-based HD cost pound32 669. The cost of home-based HD was pound20 764 per year (based on data from only one unit). The main cost drivers for PD were the costs of solutions and management of anaemia. For HD they were costs of disposables, nursing, the overheads associated with running the unit and management of anaemia.
Conclusions:
Renal tariffs for PbR need to reflect the true cost of dialysis provision if choices about modalities are not to be influenced by erroneous estimates of cost. Knowledge of the true costs of modalities will also maximize the number of established renal failure patients treated by dialysis within the limited funds available from the NHS.
Related Concept Videos
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
